Complicated coronavirus disease 2019 (COVID‐19) in a psoriatic patient treated with ixekizumab

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of dermatology 2020-08, Vol.59 (8), p.e267-e268
Hauptverfasser:	Facheris, Paola, Valenti, Mario, Pavia, Giulia, Gargiulo, Luigi, Narcisi, Alessandra, Costanzo, Antonio, Borroni, Riccardo G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized - adverse effects Betacoronavirus - immunology Betacoronavirus - isolation & purification Brugada Syndrome - complications Ceftriaxone - therapeutic use Clinical Laboratory Techniques - methods Continuous Positive Airway Pressure Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - immunology Coronavirus Infections - therapy Coronavirus Infections - virology Coronaviruses Correspondence COVID-19 COVID-19 Testing Humans Hydroxychloroquine - therapeutic use Lung Diseases, Interstitial - diagnosis Lung Diseases, Interstitial - immunology Lung Diseases, Interstitial - therapy Lung Diseases, Interstitial - virology Male Middle Aged Nasopharynx - virology Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - immunology Pneumonia, Viral - therapy Pneumonia, Viral - virology Psoriasis - complications Psoriasis - drug therapy Psoriasis - immunology SARS-CoV-2 Treatment Outcome Viral diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!